GARY W PACE
CIK 1184778 · last filed 2026-07-16
GARY W PACE is a corporate insider who has filed 86 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing shows the insider bought $1000.0K of CRDF on Jul 16, 2026. Across all open-market trades the lifetime net is −$18.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $53.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$53.88M
6
86
-$18.70M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CRDF | Director | 3,389,337 | $0.82 | $2.77M | $3.97M | 20 | 2026-07-16 |
| PCRX | Director | 22,127 | $26.81 | $593.2K | -$5.22M | 25 | 2024-03-08 |
| Cardiff Oncology, Inc. (TROV) Delisted | Director | — | — | — | $0 | 1 | 2020-05-01 |
| RMD | Director | 241,736 | $208.96 | $50.51M | -$17.54M | 29 | 2018-05-10 |
| Imunon, Inc. (CLSN) Delisted | Director | 43,356 | $1.96 | $85.0K | $47.5K | 3 | 2010-02-23 |
| Imunon, Inc. (CLN) Delisted | Director | 20,349 | — | — | $37.4K | 4 | 2008-04-29 |
Recent Filings
86 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-16 | CRDF | Buy (P) | +687,285 | $1000.0K | EDGAR |
| 2026-06-22 | CRDF | Buy (P) | +30,000 | $36.6K | EDGAR |
| 2026-06-15 | CRDF | Grant (A) | — | $0 | EDGAR |
| 2025-07-31 | CRDF | Buy (P) | +290,000 | $710.5K | EDGAR |
| 2025-06-27 | CRDF | Grant (A) | — | $0 | EDGAR |
| 2024-12-12 | CRDF | Buy (P) | +361,615 | $940.2K | EDGAR |
| 2024-07-01 | CRDF | Grant (A) | — | $0 | EDGAR |
| 2024-03-08 | PCRX | Sell (S) | −119,323 | -$3.66M | EDGAR |
| 2024-03-06 | PCRX | Notice (144) | −120,483 | -$3.58M | EDGAR |
| 2023-12-19 | CRDF | Buy (P) | +30,000 | $41.1K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.